The Bristol-Myers-financed study basically shows more is better: Give current patients higher doses of statins than before and their cholesterol levels will fall even more, further reducing the number of heart attacks.
"We want healthcare professionals and patients to have the most current information on the risks of statins, but also to assure them that these medications continue to provide an important health benefit of lowering cholesterol, " said Dr. Mary Parks, in the FDA's Center for Drug Evaluation and Research.